Literature DB >> 17715830

Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 1 diabetes mellitus.

Thanya Chetthakul1, Supawadee Likitmaskul, Nattachet Plengvidhya, Sompongse Suwanwalaikorn, Natapong Kosachunhanun, Chaicharn Deerochanawong, Sirinate Krittiyawong, Rattana Leelawatana, Yupin Benjasuratwong, Pongamorn Bunnag, Thongchai Prathipanawatr, Chardpraorn Ngarmukos, Sirima Mongkolsomlit, Petch Rawdaree.   

Abstract

OBJECTIVE: To determine the prevalence and factors associated with Diabetic Retinopathy (DR) of type 1 diabetes mellitus in Thailand. MATERIAL AND
METHOD: A cross-sectional, multicenter hospital-based study was carried out from April to December 2003. Diabetic patients in diabetic clinics of 11 tertiary centers were registered. Retinopathy was evaluated by the ophthalmologists.
RESULTS: Seven thousand one hundred and ni neteen diabetic patients received retinal examination. The number of patients with type 1 diabetes was 347. The prevalence of DR in type 1 diabetes was 21.6% (75). This consisted of Non-Proliferative DR (NPDR) 10.9% (38) and Proliferative DR (PDR) 10.7%. Patients with DR were significantly older, predominantly female, longer duration ofdiabetes, had higher BMI, systolic Blood Pressure (BP), diastolic BP serum creatinine, and TriGlycerides (TG) levels than those without DR. Both groups ofpatients were not different in term ofplasma glucose and glycosylated hemoglobin levels. Although the patients with DR had a higher percentage of overt proteinuria than those without DR, there was no difference in percentage of patients with positive microalbuminuria in both groups. This may be explained by limitation of data (only 16% had results of microalbuminuria and 19% had results of proteinuria). After adjusted for duration of diabetes, serum creatinine and smoking status, factors (adjusted odds ratio [95% confidence interval]) associated with DR were duration of diabetes 5-9.9 years (4.0 [1.49-10.91]), 10-14.9 years (6.86 [2.45-19.20]), 15-19.9 years (21.13 [7.22-61.78]), > or =20 years (22.15 [7.32-66.99]) when compared with duration of diabetes less than 5 years, serum creatinine >2 mg/dl (6.0 [2.09-17.22]) when compared with creatinine less than 2 mg/dl. From the presented model, age, gender, systolic BP >140 mmHg, diastolic BP >90 mmHg, serum TG and smoking status were not factors associated with DR.
CONCLUSION: Diabetic retinopathy affects about one fifth of type 1 diabetic patients in our study. The authors found the factors associated with DR in type 1 DM were duration of diabetes and serum creatinine. Regular screening for DR and more aggressive management of metabolic factors should be done to reduce the prevalence ofDR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17715830

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  5 in total

Review 1.  Diabetes in Thailand: Status and Policy.

Authors:  Sirimon Reutrakul; Chaicharn Deerochanawong
Journal:  Curr Diab Rep       Date:  2016-03       Impact factor: 4.810

Review 2.  Diabetes management in Thailand: a literature review of the burden, costs, and outcomes.

Authors:  Chaicharn Deerochanawong; Alessandra Ferrario
Journal:  Global Health       Date:  2013-03-14       Impact factor: 4.185

3.  Fear of Falling, Lower Extremity Strength, and Physical and Balance Performance in Older Adults with Diabetes Mellitus.

Authors:  Mantana Vongsirinavarat; Witaya Mathiyakom; Ratchanok Kraiwong; Vimonwan Hiengkaew
Journal:  J Diabetes Res       Date:  2020-06-03       Impact factor: 4.011

4.  Prevalence of and Factors Associated with Diabetic Retinopathy in Patients with Diabetes Mellitus at Siriraj Hospital - Thailand's Largest National Tertiary Referral Center.

Authors:  Thirajit Boonsaen; Sawaraj Choksakunwong; Raweewan Lertwattanarak
Journal:  Diabetes Metab Syndr Obes       Date:  2021-12-29       Impact factor: 3.168

5.  Type 1 diabetes management and outcomes: A multicenter study in Thailand.

Authors:  Prapai Dejkhamron; Jeerunda Santiprabhob; Supawadee Likitmaskul; Chaicharn Deerochanawong; Petch Rawdaree; Thipaporn Tharavanij; Sirimon Reutrakul; Chawkaew Kongkanka; Chittiwat Suprasongsin; Nawaporn Numbenjapon; Taninee Sahakitrungruang; Raweewan Lertwattanarak; Pontipa Engkakul; Apiradee Sriwijitkamol; Manassawee Korwutthikulrangsri; Rattana Leelawattana; Mattabhorn Phimphilai; Somkiat Potisat; Panthep Khananuraksa; Cherdchai Nopmaneejumruslers; Wannee Nitiyanant
Journal:  J Diabetes Investig       Date:  2020-10-04       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.